Characterization of Psoriasis
Downloads
Psoriasis is a chronic inflammatory disease, characterized by erythematous scaly plaques. The objective of the present study was to characterize epidemiologically, clinically and therapeutically adult patients with psoriasis who attended the Dermatology outpatient clinic at the San Juan de Dios General Hospital in the period from 2019 to 2024. Of 128 psoriasis records, 59.37% of the data corresponds to the female sex, with an average age of 52 years. The Metropolitan region predominated with 65.62%. The vulgar type of psoriasis represented 82.81%, the 21.09% presented cardiovascular disease. 49.22% used combined therapy with topical and systemic treatment.
Downloads
1.
Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk Factors for the Development of Psoriasis. Int J Mol Sci. 2019; 5(18):43-47. doi: 10.3390/ijms20184347
2.
Yamazaki F. Psoriasis: Comorbidities. J Dermatol. 2021; 48(6):732-740. doi: https://doi.org/10.1111%2F1346-8138.15840
3.
Zegpi MS, Cárdenas C, Sáenz ML. Psoriasis ungueal: Experiencia con el tratamiento combinado de clobetasol al 8% en laca ungueal y calcipotriol. Rev. Chilena Dermatol. 2010; 26(1):43-44. Disponible en: https://www.sochiderm.org/web/revista/26_1/6.pdf
4.
Reascos Ramón PD. Características clínicas y epidemiológicas de los pacientes con psoriasis [monografía Grado en Medicina en línea]. Ecuador: Universidad Católica de Cuenca, Unidad Académica de Salud y Bienestar; 2020. Disponible en: https://dspace.ucacue.edu.ec/server/api/core/bitstreams/4a69747f-953b-46b0-b6fc-c10e687919c2/content
5.
Arenas R. Dermatología atlas, diagnóstico y tratamiento. 7 ed. México: Mc Graw-Hill Interamericana; 2019.
6. Fernandez Torres RM. Características epidemiológicas, comorbilidades y calidad de vida de los pacientes con psoriasis en placas en el área sanitaria de Coruña [tesis Doctoral en línea]. Coruña: Universidade Da Coruña, Departamento de Medicina; 2011. Disponible en: https://ruc.udc.es/dspace/bitstream/handle/2183/10040/FernandezTorres_%20Rosa%20Maria_TD_2011.pdf?sequence=5&isAllowed=y
7. Manresa J, Juan Antonio Moreno Romero JA. Tratamientos tópicos de la psoriasis: actualización. Med Cutan Iber Lat Am. 2005; 33(4): 147-147. Disponible en: https://www.medigraphic.com/pdfs/cutanea/mc-2005/mc054b.pdf
8. Puig L. Methotrexate: New therapeutic approaches. Actas Dermo-sifiliográficas. 2014 ; 105(6): 583-589. doi:10.1016/j.ad.2012.11.017
9. Bolognia JL, Schaffer JV, Cerroni L. Dermatología. 4 ed. España: ELsevier; 2018.
10. Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019; 20(6):1475. doi: 10.3390/ijms20061475
Copyright (c) 2025 Alejandra Lol
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 |
This work is licensed under Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
| Copyright notice |
 |
Authors will retain their copyright and assign to the journal the right of first publication of their work, which will be simultaneously subject to a Creative Commons Attribution-Noncommercial-ShareAlike 4.0 International license (CC BY-NC-SA 4.0) that allows third parties to share the work as long as its author and its first publication in this magazine are indicated. |
|
Authors may adopt other non-exclusive license agreements for the distribution of the version of the published work (eg: deposit it in an institutional repository or publish it in a monographic volume) provided that the initial publication in this journal is indicated. |
|
Authors are allowed and recommended to disseminate their work through the internet (eg, in institutional telematic files or on their website) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The effect of open access). |
| About the Creative Commons license |
|
|
You are free to: |
|
Share — copy and redistribute the material in any medium or format. |
|
Adapt — remix, transform, and build upon the material. |
|
The licensor cannot revoke these freedoms as long as you follow the license terms. |
Under the following terms: |
 |
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. |
 |
NonCommercial — You may not use the material for commercial purposes. |
 |
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. |
| No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. |
